Prevalence and risk factors of retinal vein occlusion in the United States: The National Health and Nutrition Examination Survey, 2005 to 2008
- PMID: 37091777
- PMCID: PMC10120443
- DOI: 10.1080/08998280.2023.2173938
Prevalence and risk factors of retinal vein occlusion in the United States: The National Health and Nutrition Examination Survey, 2005 to 2008
Abstract
Retinal vein occlusion (RVO) is a rare, vision-threatening vascular disorder. Due to limited recovery associated with RVO, prevention is essential. There is a significant discrepancy in previously reported epidemiological studies in the United States on the prevalence and risk factors of RVO. The purpose of this retrospective, cross-sectional study was to determine the prevalence and risk factors of RVO in adults ≥40 years of age in the US using the National Health and Nutrition Examination Survey (NHANES) 2005-2008. We collected information on the demographic characteristics, medical conditions, and ocular pathology of NHANES participants. We performed weighted analysis to estimate national prevalence rates and multivariate analysis to examine associated risk factors. The main outcome measures were the prevalence of RVO and the odds ratios of associated risk factors. We included 5559 participants and found 33 cases of RVO. The overall prevalence of RVO in the US was 0.50%. Age, per 10-year increase (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.31-2.92) and elevated diastolic blood pressure, per 10 mm Hg increase (OR 1.47; 95% CI, 1.10-2.12) were significant risk factors for RVO. Race, sex, glaucoma, elevated cholesterol, and self-reported history of diabetes, stroke, and heart disease were not significant risk factors. RVO is significantly associated with older age and elevated diastolic blood pressure. Our findings should alert clinicians to identify individuals at risk for RVO.
Keywords: Epidemiology; National Health and Nutrition Examination Survey; public health; retinal vein occlusion.
Copyright © 2023 Baylor University Medical Center.
Conflict of interest statement
The authors report no funding or conflicts of interest. All data are publicly available at the NHANES website: https://www.cdc.gov/nchs/nhanes/index.htm.
Similar articles
-
Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis.Nutrients. 2025 Apr 7;17(7):1285. doi: 10.3390/nu17071285. Nutrients. 2025. PMID: 40219042 Free PMC article.
-
Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study.Medicine (Baltimore). 2016 Nov;95(44):e5185. doi: 10.1097/MD.0000000000005185. Medicine (Baltimore). 2016. PMID: 27858854 Free PMC article.
-
Retinal Vein Occlusion in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Disease Study.Ophthalmic Epidemiol. 2016;23(1):6-13. doi: 10.3109/09286586.2015.1082604. Epub 2016 Jan 11. Ophthalmic Epidemiol. 2016. PMID: 26751637
-
Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors.J Glob Health. 2019 Jun;9(1):010427. doi: 10.7189/jogh.09.010427. J Glob Health. 2019. PMID: 31131101 Free PMC article.
-
Association of glaucoma with risk of retinal vein occlusion: A meta-analysis.Acta Ophthalmol. 2019 Nov;97(7):652-659. doi: 10.1111/aos.14141. Epub 2019 May 24. Acta Ophthalmol. 2019. PMID: 31125174 Review.
Cited by
-
Development and validation of a simple and practical model for early detection of diabetic macular edema in patients with type 2 diabetes mellitus using easily accessible systemic variables.J Transl Med. 2024 May 31;22(1):523. doi: 10.1186/s12967-024-05328-y. J Transl Med. 2024. PMID: 38822359 Free PMC article.
-
Jueling Mingmu decoction combined with ranibizumab for retinal vein occlusion induced macular edema: A randomized controlled clinical trial.Int Ophthalmol. 2025 Sep 2;45(1):372. doi: 10.1007/s10792-025-03738-5. Int Ophthalmol. 2025. PMID: 40892272 Free PMC article. Clinical Trial.
-
Effect of simultaneous intravitreal ranibizumab and extended-release dexamethasone injection on patients with naïve versus refractory retinal vein occlusion macular edema: a prospective, multicenter, and interventional open-label study.Int J Ophthalmol. 2025 May 18;18(5):860-867. doi: 10.18240/ijo.2025.05.11. eCollection 2025. Int J Ophthalmol. 2025. PMID: 40385115 Free PMC article.
-
Is retinal vein occlusion highly associated with an increased risk of myocardial infarction? A systematic review and meta-analysis.Int J Retina Vitreous. 2024 Nov 12;10(1):86. doi: 10.1186/s40942-024-00606-9. Int J Retina Vitreous. 2024. PMID: 39533338 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources